Vestal Point Capital, LP Ultragenyx Pharmaceutical Inc. Transaction History
Vestal Point Capital, LP
- $1.32 Trillion
- Q3 2024
A detailed history of Vestal Point Capital, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 750,000 shares of RARE stock, worth $31.7 Million. This represents 3.16% of its overall portfolio holdings.
Number of Shares
750,000
Previous 1,800,000
58.33%
Holding current value
$31.7 Million
Previous $74 Billion
43.68%
% of portfolio
3.16%
Previous 5.52%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$420 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$237 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$216 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$176 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$130 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.96B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...